In this report, the United States Neurointerventional Devices Market is valued at USD XX million in 2019 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2019 and 2025.
Neurointerventional devices are advanced medical specialty instrument that uses minimally invasive endovascular techniques. This device is used during minimally invasive surgery during the treatment of vascular diseases of the brain. The neuro intervention is a medical condition that is basically occurring inside the spinal cavity or vessels of the brain. Neurointervention is gaining huge demand amongst neuro-specialists due to its minimal invasiveness nature and neuro intervention also has a significant success rate.
Growing cases of stroke and aneurysm in the U.S. region is projected to foster the market growth of Neurointerventional devices. According to the Brain Aneurysm Foundation, an estimated 6.5 million people in the United States have an unruptured brain aneurysm or 1 in 50 people. Increasing focus of manufacturers to introduce advanced technology and expand their presence in the U.S. market is further estimated to foster the market growth of neurointerventional devices. For instance, in July 2017, Johnson & Johnson Medical Devices Companies introduced CERENOVUS, its new neurovascular business, at the Society of NeuroInterventional Surgery (SNIS) 14th Annual Meeting in Colorado. CERENOVUS will focus on offering innovative therapies for hemorrhagic and ischemic stroke patients.
Key Developments:
- In July 2019, Penumbra announced U.S. commercial availability of the Penumbra System’s advanced technology, the Penumbra Jet 7 Reperfusion Catheter with Xtra Flex technology, at the Society of NeuroInterventional Surgery (SNIS) 16th Annual Meeting.
- In Luly 2018, MicroVention, Inc. a U.S.-based subsidiary of Terumo and a neurovascular company, announced the FDA clearance of a new clinical indication for the SOFIA® Catheter (Soft TOrqueable catheter For Intracranial Access) to include contact aspiration technique for successful revascularization among patients with acute ischemic stroke, secondary to intracranial large vessel occlusive disease.
- In October 2017, Vesalio announces the CE Mark certification of its first product line, the proprietary NeVa™ neuro thrombectomy platform for the treatment of strokes.
- In July 2019, Medtronic and Viz.ai have partnered to promote the adoption of Viz.ai’s new technology, which helps to synchronize stroke care and decrease time to treatment, potentially improving outcomes for patients. Viz.ai’s technology uses artificial intelligence (AI) to identify suspected large vessel occlusion (LVO) strokes and automatically notify specialists.
- In October 2017, Johnson & Johnson aquired Codman Neurosurgery business to Integra LifeSciences Holding Corporation for an approximate value of $1.045 billion. The Codman Neurosurgery business provide a portfolio of devices focused on hydrocephalus management, neurointensive care, and cranial surgery, and generated net revenues of approximately $371.5 million in 2016.
Geographically, this report splits the United States market into seven regions:
╼ The West
╼ Southwest
╼ The Middle Atlantic
╼ New England
╼ The South
╼ The Midwest
with sales (volume), revenue (value), market share and growth rate of Neurointerventional Devices in these regions, from 2014 to 2025 (forecast).
United States Neurointerventional Devices market competition by top manufacturers/players, with Neurointerventional Devices sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
╼ Codman & Shurtleff
╼ Integra Life Sciences
╼ Medtronic
╼ Stryker
╼ Boston Scientific
╼ BrainLab
╼ Elekta
╼ Karl Storz
╼ Micromar
╼ Scopis
╼ SPR Therapeutics
╼ St. Jude Medical
╼ Synapse Biomedical
╼ Aesculap(B.Braun)
╼ TeDan Surgical Innovations
╼ Kogent Surgical
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
╼ Embolic Coils
╼ Neurovascular Stents (Carotid Stents and Intracranial Stents)
╼ Neurovascular Thrombectomy Devices
╼ Intrasaccular Devices
╼ Embolic Protection Devices
╼ Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Neurointerventional Devices for each application, including
╼ Hospitals
╼ Ambulatory Surgical Centers
╼ Others
** If you have any special requirements, please let us know and we will offer you the report as you want.
Table of Contents
United States Neurointerventional Devices Market Report 2019
1 Neurointerventional Devices Overview
1.1 Product Overview and Scope of Neurointerventional Devices
1.2 Classification of Neurointerventional Devices by Product Category
1.2.1 United States Neurointerventional Devices Market Size (Sales Volume) Comparison by Type (2014-2025)
1.2.2 United States Neurointerventional Devices Market Size (Sales Volume) Market Share by Type (Product Category) in 2018
1.2.3 Embolic Coils
1.2.4 Neurovascular Stents (Carotid Stents and Intracranial Stents)
1.2.5 Neurovascular Thrombectomy Devices
1.2.6 Intrasaccular Devices
1.2.7 Embolic Protection Devices
1.2.8 Others
1.3 United States Neurointerventional Devices Market by Application/End Users
1.3.1 United States Neurointerventional Devices Market Size (Consumption) and Market Share Comparison by Application (2014-2025)
1.3.2 Hospitals
1.3.3 Ambulatory Surgical Centers
1.3.4 Others
1.4 United States Neurointerventional Devices Market by Region
1.4.1 United States Neurointerventional Devices Market Size (Value) Comparison by Region (2014-2025)
1.4.2 The West Neurointerventional Devices Status and Prospect (2014-2025)
1.4.3 Southwest Neurointerventional Devices Status and Prospect (2014-2025)
1.4.4 The Middle Atlantic Neurointerventional Devices Status and Prospect (2014-2025)
1.4.5 New England Neurointerventional Devices Status and Prospect (2014-2025)
1.4.6 The South Neurointerventional Devices Status and Prospect (2014-2025)
1.4.7 The Midwest Neurointerventional Devices Status and Prospect (2014-2025)
1.5 United States Market Size (Value and Volume) of Neurointerventional Devices (2014-2025)
1.5.1 United States Neurointerventional Devices Sales and Growth Rate (2014-2025)
1.5.2 United States Neurointerventional Devices Revenue and Growth Rate (2014-2025)
2 United States Neurointerventional Devices Market Competition by Players/Suppliers
2.1 United States Neurointerventional Devices Sales and Market Share of Key Players/Suppliers (2014-2019)
2.2 United States Neurointerventional Devices Revenue and Share by Players/Suppliers (2014-2019)
2.3 United States Neurointerventional Devices Average Price by Players/Suppliers (2014-2019)
2.4 United States Neurointerventional Devices Market Competitive Situation and Trends
2.4.1 United States Neurointerventional Devices Market Concentration Rate
2.4.2 United States Neurointerventional Devices Market Share of Top 3 and Top 5 Players/Suppliers
2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Neurointerventional Devices Manufacturing Base Distribution, Sales Area, Product Type
3 United States Neurointerventional Devices Sales (Volume) and Revenue (Value) by Region (2014-2019)
3.1 United States Neurointerventional Devices Sales and Market Share by Region (2014-2019)
3.2 United States Neurointerventional Devices Revenue and Market Share by Region (2014-2019)
3.3 United States Neurointerventional Devices Price by Region (2014-2019)
4 United States Neurointerventional Devices Sales (Volume) and Revenue (Value) by Type (Product Category) (2014-2019)
4.1 United States Neurointerventional Devices Sales and Market Share by Type (Product Category) (2014-2019)
4.2 United States Neurointerventional Devices Revenue and Market Share by Type (2014-2019)
4.3 United States Neurointerventional Devices Price by Type (2014-2019)
4.4 United States Neurointerventional Devices Sales Growth Rate by Type (2014-2019)
5 United States Neurointerventional Devices Sales (Volume) by Application (2014-2019)
5.1 United States Neurointerventional Devices Sales and Market Share by Application (2014-2019)
5.2 United States Neurointerventional Devices Sales Growth Rate by Application (2014-2019)
5.3 Market Drivers and Opportunities
6 United States Neurointerventional Devices Players/Suppliers Profiles and Sales Data
6.1 Codman & Shurtleff
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Neurointerventional Devices Product Category, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Codman & Shurtleff Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.1.4 Main Business/Business Overview
6.2 Integra Life Sciences
6.2.2 Neurointerventional Devices Product Category, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Integra Life Sciences Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.2.4 Main Business/Business Overview
6.3 Medtronic
6.3.2 Neurointerventional Devices Product Category, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Medtronic Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.3.4 Main Business/Business Overview
6.4 Stryker
6.4.2 Neurointerventional Devices Product Category, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 Stryker Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.4.4 Main Business/Business Overview
6.5 Boston Scientific
6.5.2 Neurointerventional Devices Product Category, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Boston Scientific Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.5.4 Main Business/Business Overview
6.6 BrainLab
6.6.2 Neurointerventional Devices Product Category, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 BrainLab Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.6.4 Main Business/Business Overview
6.7 Elekta
6.7.2 Neurointerventional Devices Product Category, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Elekta Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.7.4 Main Business/Business Overview
6.8 Karl Storz
6.8.2 Neurointerventional Devices Product Category, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Karl Storz Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.8.4 Main Business/Business Overview
6.9 Micromar
6.9.2 Neurointerventional Devices Product Category, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Micromar Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.9.4 Main Business/Business Overview
6.10 Scopis
6.10.2 Neurointerventional Devices Product Category, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Scopis Neurointerventional Devices Sales, Revenue, Price and Gross Margin (2014-2019)
6.10.4 Main Business/Business Overview
6.11 SPR Therapeutics
6.12 St. Jude Medical
6.13 Synapse Biomedical
6.14 Aesculap ?B. Braun?
6.15 TeDan Surgical Innovations
6.16 Kogent Surgical
7 Neurointerventional Devices Manufacturing Cost Analysis
7.1 Neurointerventional Devices Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Neurointerventional Devices
8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Neurointerventional Devices Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Neurointerventional Devices Major Manufacturers in 2018
8.4 Downstream Buyers
9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List
10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change
11 United States Neurointerventional Devices Market Size (Value and Volume) Forecast (2019-2025)
11.1 United States Neurointerventional Devices Sales Volume, Revenue Forecast (2019-2025)
11.2 United States Neurointerventional Devices Sales Volume Forecast by Type (2019-2025)
11.3 United States Neurointerventional Devices Sales Volume Forecast by Application (2019-2025)
11.4 United States Neurointerventional Devices Sales Volume Forecast by Region (2019-2025)
12 Research Findings and Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
Request Discount 
Inquire Before Buy
